Similar biological medicinal products containing monoclonal antibodies: non-clinical and clinical issues

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/CHMP/BMWP/403543/2010
Effective from01/12/2012
KeywordsBiosimilars, monoclonal antibodies, similar biological medicinal products, relevant animal model, non-clinical studies, in vitro studies, clinical use, clinical endpoints, extrapolation
DescriptionThis document lays down the non-clinical and clinical requirements for monoclonal antibody (mAb) containing medicinal products claiming to be similar to another one already authorised.

Document history

First version

Current version

Adopted guideline

Overview of comments

Draft guideline

Concept paper

In operation: 01/12/2012–present

Published: 15/06/2012

Published: 26/11/2010

Published: 17/11/2009

Related content

How helpful is this page?

Average rating:

 Based on 38 ratings

Add your rating:

See all ratings
7 ratings
7 ratings
8 ratings
7 ratings
9 ratings

Tell us more